Clermont-Oncology-VieCure.jpg

Clermont Oncology Center and VieCure Join Forces to Accelerate Cancer Excellence in the Clermont, Florida, Community

July 22, 2021

Clermont Oncology Center announced their decision to adopt VieCure’s  A.I. Enabled Oncology Clinical Decision Support Platform as part of enhancing cancer care excellence in the Clermont Community.

DENVER, Colorado and CLERMONT, Florida — Clermont Oncology has been treating Clermont patients for over 23 years under the leadership of Dr. Gopal Kunta. The practice specializes in Hematology, Oncology and Internal Medicine. Bringing precision oncology to the community reflects Clermont Oncology’s continuous commitment to providing next generation technology to the area’s patients. The practice selected VieCure’s artificial intelligence (A.I.) enabled platform over a number of traditional oncology EMR systems given the access to VieCure’s clinical decision support platform and codified clinical content. 

 

Dr. Gopal Kunta, MD, “Clermont is committed to providing patients access to affordable, high-quality cancer care.  We believe in the value of providing care through a community cancer setting, making care widely available to patients close to home, where they are treated by physicians and staff focused on providing exceptional care. With VieCure, we have a collaboration where our patients benefit from leading edge technology conbined with Clermont Oncology’s expertise in cost-effective oncology care for the local community.”

 

VieCure, a Denver based cancer care company, develops technology that combines an A.I. engine with an extensive clinical knowledge library and integrated electronic medical record system. It provide’s real-time decision support for a cancer care team as they develop a personalized treatment plan for patients, suggesting treatment adjustments based on the patient’s response and test results (including next generation tumor sequencing and proteomics). The A.I. engine and knowledge base integrate with the EMR and connect to a mobile patient app which then allows the cancer care team to assist with remote patient monitoring, treatment compliance and symptom management.

 

Michael Power, Chief Sales and Business Development Officer, “Clermont Oncology Center and VieCure have recognized a unique opportunity to work together to create a showpiece of cancer treatment excellence. The Clermont Oncology team will benefit from improved clinical decision-making at the individual patient level, while standardizing care plans and associated care delivery. The real-time date generated with the VieCure Platform as patients move throughout their complex cancer care journey will help Celermont Oncology evaluate treatment approaches and improve treatment outcomes.”

About Clermont Oncology Center

Clermont Oncology Center is a state of the art 5,200 sq. ft. cancer facility providing high quality Medical Oncology and Hematology services to the community of Clermont and beyond. Visiting Clermont Oncology Center ensures a high-quality experience with qualified healthcare professionals who are knowledgeable, compassionate and committed.  The speciality pharmacy ensures patients benefit from a one-stop shop experience. For patients in need of assistance for high out-of-pocket costs, Clermont Oncology is proud to support them through foundations. The team empowers people through open and honest communication; they strive to earn the loyalty of every person they serve.

For Clermont Oncology

Sukanya Reddy

Practice Administrator 

sukanya@clermontoncology.com

Clermont Oncology_edited.jpg

About VieCure

VieCure has developed a proprietary artificial intelligence informatics software platform in conjunction with a clinical inference engine and smart electronic medical record in oncology. The VieCure™ platform is a real-time decision support system that combines clinical knowledge with patient data to assist oncologists and hematologists in generating personalized treatment plans and managing a patient's treatment throughout diagnosis, cancer therapy, and ongoing follow-up care.  VieCure has contracted with cancer centers in the United States, in the Bahamas, and in Antigua and has forged meaningful strategic alliances with global pharmaceutical companies, molecular diagnostic companies, and lab companies.

For VieCure

Michael G. Power, BA, MIM

Chief Business Development Officer

michael.power@viecure.com.

logo-wordmark-full-color.jpg